Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general population
- PMID: 25754080
- PMCID: PMC4759203
- DOI: 10.1038/mp.2015.12
Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general population
Abstract
Cognitive impairment is common among individuals diagnosed with autism spectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD). It has been suggested that some aspects of intelligence are preserved or even superior in people with ASD compared with controls, but consistent evidence is lacking. Few studies have examined the genetic overlap between cognitive ability and ASD/ADHD. The aim of this study was to examine the polygenic overlap between ASD/ADHD and cognitive ability in individuals from the general population. Polygenic risk for ADHD and ASD was calculated from genome-wide association studies of ASD and ADHD conducted by the Psychiatric Genetics Consortium. Risk scores were created in three independent cohorts: Generation Scotland Scottish Family Health Study (GS:SFHS) (n=9863), the Lothian Birth Cohorts 1936 and 1921 (n=1522), and the Brisbane Adolescent Twin Sample (BATS) (n=921). We report that polygenic risk for ASD is positively correlated with general cognitive ability (beta=0.07, P=6 × 10(-7), r(2)=0.003), logical memory and verbal intelligence in GS:SFHS. This was replicated in BATS as a positive association with full-scale intelligent quotient (IQ) (beta=0.07, P=0.03, r(2)=0.005). We did not find consistent evidence that polygenic risk for ADHD was associated with cognitive function; however, a negative correlation with IQ at age 11 years (beta=-0.08, Z=-3.3, P=0.001) was observed in the Lothian Birth Cohorts. These findings are in individuals from the general population, suggesting that the relationship between genetic risk for ASD and intelligence is partly independent of clinical state. These data suggest that common genetic variation relevant for ASD influences general cognitive ability.
Conflict of interest statement
AMM has received financial support from Pfizer (formerly Wyeth), Janssen and Lilly. AMM has done consultancy work for Roche Pharmaceuticals. The other authors declare no conflict of interest.
Figures


Similar articles
-
Psychiatric Polygenic Risk Scores as Predictor for Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in a Clinical Child and Adolescent Sample.Behav Genet. 2020 Jul;50(4):203-212. doi: 10.1007/s10519-019-09965-8. Epub 2019 Jul 25. Behav Genet. 2020. PMID: 31346826 Free PMC article.
-
Autism spectrum disorder polygenic scores are associated with every day executive function in children admitted for clinical assessment.Autism Res. 2020 Feb;13(2):207-220. doi: 10.1002/aur.2207. Epub 2019 Sep 30. Autism Res. 2020. PMID: 31571410 Free PMC article.
-
Associations of polygenic risk scores differentiating attention-deficit hyperactivity disorder from autism spectrum disorder with cognitive and cortical alterations in Schizophrenia patients.Eur Child Adolesc Psychiatry. 2025 Mar;34(3):1149-1159. doi: 10.1007/s00787-024-02549-w. Epub 2024 Aug 7. Eur Child Adolesc Psychiatry. 2025. PMID: 39110189 Free PMC article.
-
Comparative meta-analyses of brain structural and functional abnormalities during cognitive control in attention-deficit/hyperactivity disorder and autism spectrum disorder.Psychol Med. 2020 Apr;50(6):894-919. doi: 10.1017/S0033291720000574. Epub 2020 Mar 27. Psychol Med. 2020. PMID: 32216846 Free PMC article.
-
A Review of the Default Mode Network in Autism Spectrum Disorders and Attention Deficit Hyperactivity Disorder.Brain Connect. 2021 May;11(4):253-263. doi: 10.1089/brain.2020.0865. Epub 2021 Feb 18. Brain Connect. 2021. PMID: 33403915 Free PMC article. Review.
Cited by
-
'Big data' in mental health research: current status and emerging possibilities.Soc Psychiatry Psychiatr Epidemiol. 2016 Aug;51(8):1055-72. doi: 10.1007/s00127-016-1266-8. Epub 2016 Jul 27. Soc Psychiatry Psychiatr Epidemiol. 2016. PMID: 27465245 Free PMC article. Review.
-
Effects of polygenic risk for major mental disorders and cross-disorder on cortical complexity.Psychol Med. 2021 Apr 8;52(16):1-12. doi: 10.1017/S0033291721001082. Online ahead of print. Psychol Med. 2021. PMID: 33827729 Free PMC article.
-
Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (N=112 151) and 24 GWAS consortia.Mol Psychiatry. 2016 Nov;21(11):1624-1632. doi: 10.1038/mp.2015.225. Epub 2016 Jan 26. Mol Psychiatry. 2016. PMID: 26809841 Free PMC article.
-
Polygenic Scores Clarify the Relationship Between Mental Health and Gender Diversity.Biol Psychiatry Glob Open Sci. 2024 Jan 24;4(2):100291. doi: 10.1016/j.bpsgos.2024.100291. eCollection 2024 Mar. Biol Psychiatry Glob Open Sci. 2024. PMID: 38425476 Free PMC article.
-
Clinical autism subscales have common genetic liabilities that are heritable, pleiotropic, and generalizable to the general population.Transl Psychiatry. 2022 Jun 13;12(1):247. doi: 10.1038/s41398-022-01982-2. Transl Psychiatry. 2022. PMID: 35697691 Free PMC article.
References
-
- 2Larsson H, Dilshad R, Lichtenstein P, Barker ED. Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology. J Child Psychol Psychiatry 2011; 52: 954–963. - PubMed
-
- 3Lichtenstein P, Carlstrom E, Rastam M, Gillberg C, Anckarsater H. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry 2010; 167: 1357–1363. - PubMed
-
- 4Sherman DK, McGue MK, Iacono WG. Twin concordance for attention deficit hyperactivity disorder: a comparison of teachers' and mothers' reports. Am J Psychiatry 1997; 154: 532–535. - PubMed
Publication types
MeSH terms
Grants and funding
- 104036/WT_/Wellcome Trust/United Kingdom
- CZD/16/6/CSO_/Chief Scientist Office/United Kingdom
- MR/K026992/1/MRC_/Medical Research Council/United Kingdom
- 104036/Z/14/Z/WT_/Wellcome Trust/United Kingdom
- G0700704/MRC_/Medical Research Council/United Kingdom
- BB/F019394/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- ETM/55/CSO_/Chief Scientist Office/United Kingdom
- CZB/4/505/CSO_/Chief Scientist Office/United Kingdom
- CZD/16/6/4/CSO_/Chief Scientist Office/United Kingdom
- MC_PC_U127561128/MRC_/Medical Research Council/United Kingdom
- HR03006/CSO_/Chief Scientist Office/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical